ArticleEuropean journal of epidemiology2026
Impact of hypothyroidism and hyperthyroidism on endometrial cancer incidence: results from a large population-based cohort study.
Article in European journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The limited number of studies examining the association between thyroid diseases and endometrial cancer have yielded inconsistent findings. The study aimed to examine the association between hypothyroidism and hyperthyroidism and the risk of endometrial cancer using comprehensive nationwide register data from Denmark. We conducted a population-based cohort study including 1,057,937 women born in Denmark between 1960 and 1997. Information on thyroid disease diagnoses, cancer diagnoses, covariates, migration, and vital status was obtained from nationwide Danish health and administrative registers. Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for endometrial cancer overall and for type I tumors. A landmark analysis examined risks associated with exposures before age 40, and pseudo-observation methods estimated absolute risk differences. During a median follow-up of 17.5 years, 1,159 women were diagnosed with endometrial cancer. Women with hypothyroidism had a higher rate of overall endometrial cancer (HR: 1.53, 95% CI: 1.22-1.93) and type I tumors (HR: 1.64, 95% CI: 1.12-2.41). These associations were consistent across subgroups defined by menopausal status and time since diagnosis. No association was observed for hyperthyroidism (HR: 1.14, 95% CI: 0.80-1.62). In the landmark analysis, hypothyroidism remained associated with an increased endometrial cancer rate, but the absolute risk difference by age 60 was modest and not statistically significant. In conclusion, hypothyroidism was associated with a modestly increased rate of endometrial cancer, while no association was observed for hyperthyroidism. These findings support further investigation into thyroid function and endometrial carcinogenesis.
Indexed as
Identifiers
41879965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.